Gufic Biosciences is currently trading at Rs. 97.40, up by 1.90 points or 1.99% from its previous closing of Rs. 95.50 on the BSE.
The scrip opened at Rs. 94.90 and has touched a high and low of Rs. 103.00 and Rs. 92.85 respectively. So far 299877 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 103.00 on 30-Nov-2017 and a 52 week low of Rs. 45.00 on 02-Dec-2016.
Last one week high and low of the scrip stood at Rs. 103.00 and Rs. 90.10 respectively. The current market cap of the company is Rs. 743.72 crore.
The promoters holding in the company stood at 69.98%, while Institutions and Non-Institutions held 8.88% and 21.14% respectively.
Gufic Biosciences has received two Patent Certificates from the Intellectual Property India, The Patent Office. The Government of India has granted patents to the company for the following formulations—a freeze dried pharmaceutical formulation of rifabutin and process for preparation thereof and process for preparation of parental formulation of Micafungin Sodium.
Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.
